Brendan actively engages with external stakeholders to support our industry and demonstrate the value of our medicines to policymakers. He has educated state legislators on the drug supply chain and value-based insurance designs so that legislators have the knowledge to make informed decisions about legislation seeking to ensure patient access to affordable medicines.